| Date Filed | Type | Description |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
3
| Jacob Jeffrey E. (Director) has filed a Form 3 on Panbela Therapeutics, Inc. |
| 06/24/2022 |
3
| Donovan Daniel (Director) has filed a Form 3 on Panbela Therapeutics, Inc. |
| 09/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2021 |
4
| Horvath Susan (V.P. of Finance & CFO) has filed a Form 4 on Panbela Therapeutics, Inc.|
Txns:
| Granted 12,135 options to buy
@ $2.26, valued at
$27.4k
|
|
| 06/11/2021 |
4
| Gagnon Suzanne (Director) has filed a Form 4 on Panbela Therapeutics, Inc.|
Txns:
| Gifted 7,142 shares
@ $0
Gifted 3,284 shares
@ $0
Gifted 1,000 shares
@ $0 |
|
| 05/27/2021 |
4
| Fratamico Arthur (Director) has filed a Form 4 on Panbela Therapeutics, Inc.|
Txns:
| Granted 4,316 shares
@ $0
Granted 12,368 options to buy
@ $4.17, valued at
$51.6k
|
|
| 05/27/2021 |
4
| Schemel Donald Robert (10% Owner) has filed a Form 4 on Panbela Therapeutics, Inc.|
Txns:
| Granted 4,316 shares
@ $0
Granted 12,368 options to buy
@ $4.17, valued at
$51.6k
|
|
| 05/27/2021 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on Panbela Therapeutics, Inc.|
Txns:
| Granted 4,316 shares
@ $0
Granted 12,368 options to buy
@ $4.17, valued at
$51.6k
|
|
| 05/27/2021 |
4
| Schaffer Paul W. (Director) has filed a Form 4 on Panbela Therapeutics, Inc.|
Txns:
| Granted 4,316 shares
@ $0
Granted 12,368 options to buy
@ $4.17, valued at
$51.6k
|
|
| 05/27/2021 |
4
| Cullen Michael T. (10% Owner) has filed a Form 4 on Panbela Therapeutics, Inc.|
Txns:
| Granted 4,316 shares
@ $0
Granted 12,368 options to buy
@ $4.17, valued at
$51.6k
|
|
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Horvath Susan (V.P. of Finance & CFO) has filed a Form 4 on Panbela Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $4.09, valued at
$163.6k
|
|
| 04/01/2021 |
4
| Gagnon Suzanne (Director) has filed a Form 4 on Panbela Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $4.09, valued at
$143.2k
|
|
| 04/01/2021 |
4
| Cullen Michael T. (Executive Chairman) has filed a Form 4 on Panbela Therapeutics, Inc.|
Txns:
| Granted 55,000 options to buy
@ $4.09, valued at
$225k
|
|
| 12/03/2020 |
4
| Schaffer Paul W. (Director) has filed a Form 4 on Panbela Therapeutics, Inc.|
Txns:
| Granted 2,875 shares
@ $0 |
|
| 12/03/2020 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on Panbela Therapeutics, Inc.|
Txns:
| Granted 2,875 shares
@ $0 |
|
| 12/03/2020 |
4
| Schemel Donald Robert (10% Owner) has filed a Form 4 on Panbela Therapeutics, Inc.|
Txns:
| Granted 2,875 shares
@ $0 |
|
| 12/03/2020 |
4
| Fratamico Arthur (Director) has filed a Form 4 on Panbela Therapeutics, Inc.|
Txns:
| Granted 2,875 shares
@ $0 |
|
| 09/14/2020 |
4
| Simpson Jennifer K. (President and CEO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Bought 1,000 shares
@ $2.7371, valued at
$2.7k
|
|
| 09/09/2020 |
4
| Schaffer Paul W. (Director) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Bought 24,775 shares
@ $2.5089, valued at
$62.2k
Bought 225 shares
@ $2.55, valued at
$573.8 |
|
| 09/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|